April 3, 2021: Pfizer/BioNTech have announced their COVID-19 vaccine affords at least 6 months of protection following the second dose. The vaccine was 91.3% effective against COVID-19 in an analysis of 927 symptomatic people through March 13, as indicated by real-world data compiled since the vaccine was given emergency use authorization.

